'FDA' Category
By Simmons Hanly Conroy | November 12, 2013
Help Make Generic Drug Manufacturers Accountable for Safety by Signing Take Justice Back Petition
FDA proposes rule changes to hold generic drug manufacturers accountable for injuries The FDA has proposed new rules that would improve generic drug manufacturer accountability. More than 80 percent of prescriptions are… Read More
By Simmons Hanly Conroy | October 25, 2013
FDA Issues Black Box Warning on Two Cancer Drugs
The hepatitis B warnings on two blood cancer drugs were recently strengthened by the Food and Drug Administration (FDA), according to Fox News. The strengthened warnings were issued to reflect the risk of… Read More
By Simmons Hanly Conroy | September 6, 2013
FDA Strengthens Warning on Lariam, Anti-Malaria Drug
Recently, the Food and Drug Administration (FDA) announced that the commonly used anti-malaria drug, called mefloquine hydrochloride (brand name Lariam) must have a “black box” warning on its label. The drug has… Read More
By Simmons Hanly Conroy | July 8, 2013
FDA To Revisit Rule Blocking Lawsuits Against Generic Drug Makers
The U.S. Food & Drug Administration has indicated it might allow generic drug manufacturers to revise their products’ safety labels independent of their name brand counterparts. If this change is made, consumers harmed by… Read More
By Simmons Hanly Conroy | April 11, 2013
New Type of Diabetes Drug Approved by FDA
A Johnson & Johnson drug that treats type 2 diabetes in a new way is now approved by the U.S. Food and Drug Administration (FDA). Invokana, as the drug is known, will… Read More
By Simmons Hanly Conroy | February 5, 2013
Research Finds Female Lipitor Users Have Increased Risk of Diabetes
Three studies have determined women who take the cholesterol-lowering drug Lipitor have an increased risk of developing Type 2 Diabetes. In one study published by The Archives of Internal Medicine, the risk for older… Read More
By Simmons Hanly Conroy | December 31, 2012
The FDA’s Role in Dealing with Drug Shortages
When Ameridose, the company linked to the recent meningitis outbreaks and production of contaminated steroid injections closed its doors for the remainder of the year, many people worried about drug shortages. Since then, the… Read More
By Simmons Hanly Conroy | October 30, 2012
Pradaxa and Chantix Account for the Most Drug Complaints to the FDA
The October 2012 QuarterWatch report from the Institute for Safe Medication Practices details the number of drug complaints received by the FDA over the past four years. Prescription medication complaints issued to the FDA… Read More
By Simmons Hanly Conroy | May 15, 2012
FDA Label Requirements Fail Consumers Harmed by Generic Defective Drugs
Generic Drug Manufacturers Should Have a Duty to Warn Consumers of New Safety Concerns Generic drugs account for seventy-five percent of filled prescriptions. Buying generic saves money and, often, the drug is… Read More
By Simmons Hanly Conroy | April 10, 2012
FDA Requires Labels of Drospirenone Birth Control, Like Yaz, to Include Increased Blood Clot Risk Warning
The requirements levied against Bayer and its popular birth control Yaz became stricter today. The Food & Drug Administration has issued a safety alert regarding birth control that contains drospirenone, like Yaz and Yasmine,… Read More
